The expression of microRNA-23a regulates acute myocardial infarction in patients and in vitro through targeting PTEN.

Molecular Medicine Reports
Shengli LiQianmei Sun

Abstract

Cardiovascular disease is responsible for one of the highest rates of fatality worldwide. The present study investigated the presence and influence of microRNA (miRNA)-23a in the regulation of acute myocardial infarction (AMI). A total of 6 patients with AMI and 6 normal volunteers without myocardial disease were included, and blood samples were taken to analyze the expression of miRNA‑23a by reverse transcription‑quantitative polymerase chain reaction. miRNA‑23a expression in patients with AMI was downregulated compared with the normal group. In H9C2 cells treated with H2O2, upregulation of miRNA‑23a expression increased the superoxide dismutase, glutathione and catalase activity levels, and suppressed the malonaldehyde activity level, as determined by ELISA. Western blot analysis and a caspase‑3 substrate assay demonstrated that upregulation of miRNA‑23a expression suppressed the Bcl‑2‑associated X (Bax)/Bcl‑2 protein expression ratio, caspase‑3 activity level and tumor suppressor p53 (p53) protein expression in H2O2‑induced H9C2 cells. Furthermore, downregulation of phosphatase and tensin homolog (PTEN), by the PTEN inhibitor bpV(HOpic), increased miRNA‑23a expression and suppressed the Bax/Bcl‑2 protein expression ratio, ca...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jan 26, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Kyle T KeyesYumei Ye
Jan 8, 2011·Journal of the American College of Cardiology·Mariela AgostoBruce T Liang
Sep 22, 2012·Biochemical and Biophysical Research Communications·Sen MatsumotoIssei Komuro
Nov 28, 2013·Cardiovascular Therapeutics·Andrew J BoyleRandall J Lee
May 23, 2014·Circulation. Cardiovascular Interventions·Lorenz RäberUNKNOWN COMFORTABLE AMI Trial Investigators
Jul 12, 2014·BioMed Research International·Elsa Bronze-da-Rocha
Sep 17, 2014·Clinical and Experimental Pharmacology & Physiology·Yao-Jun ZhangShao-Liang Chen
Oct 12, 2014·Cell Biochemistry and Biophysics·Ke-qin LuoBing-can Xu
Dec 17, 2014·Nature Reviews. Cardiology·Reinier A Boon, Stefanie Dimmeler
Sep 1, 2015·Biochemical and Biophysical Research Communications·Chi WangJinchao Zhang
Dec 18, 2015·Postępy w kardiologii interwencyjnej = Advances in interventional cardiology·Ahmet HaziniHüseyin Uyarel

❮ Previous
Next ❯

Citations

Jun 25, 2020·International Journal of Molecular Sciences·Montserrat ClimentAlessandra Castaldi
Jun 3, 2021·International Journal of Molecular Sciences·Mihir Parikh, Grant N Pierce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.